KEAP1 and head and neck squamous cell carcinoma: Given the fact that Keap1 mutations and Nrf2 overexpression lead to chemotherapeutic resistance, we, therefore, hypothesized that Keap1 mutations might lead to an increased rate of local recurrence in advanced HNSCC patients treated with chemotherapeutic agents.